However, when the correlation between the expression levels of DDB2 and the AR in human prostate cancer tissues was analyzed, a positive correlation of the expression of these two proteins was revealed (Supplementary Table 1A), an observation that may not match our proposed model of DDB2-mediated AR degradation in the LNCaP cell line. Here, DDB2 is linked to prostate carcinoma.